Medical experts are proposing a new name for polycystic ovary syndrome (PCOS), suggesting it be called PMOS, according to a report from Patient Care Online published on August 31, 2026. The proposed change is intended to better reflect the condition's nature for clinicians and patients alike.
Patient Care Online reports that the name shift from PCOS to PMOS is being discussed as a way to improve accuracy in diagnosis and treatment. The condition, which affects approximately one in eight women, has long been known by its current name, but experts argue the terminology may no longer align with the latest medical understanding.
The discussion comes amid broader efforts to refine how the condition is classified and communicated. According to the report, the new name is part of a push to help clinicians recognize the full scope of the disorder, which extends beyond ovarian symptoms. The change is also seen as a step toward reducing confusion among patients who may not fit the traditional "polycystic" description.
Patient Care Online notes that the proposal has gained attention in medical circles, with some outlets highlighting the importance of the terminology shift for awareness initiatives. The name change is not yet official, but it signals a growing consensus among experts that current labels may be outdated.
As the conversation develops, clinicians and patient advocates will likely watch for formal adoption of the new term by major medical organizations. A final decision could reshape how the condition is taught, diagnosed, and discussed in the years ahead.
